Abiopharma

Jushi Holdings Inc. Announces Amendment to CEO Employment Agreement

Zynex Financial Restructuring Puts Company on Path to Long-Term Success

Lipocines PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital

Zimmer Biomet Holdings, Inc. Notification

Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ITGR

Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million

Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University

Insulet - Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference